← Leaderboards
Mathewos Tessema
Lovelace Biomedical & Environmental Research Institute
$1,533,498
Attributed
$3,066,995
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $586.2K · FY2012–20$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,066,995 · 2
By mechanism
R01$2,590,783 · 1
R21$476,212 · 1
Top collaborators
- Philip Kuehl5 shared
- Jerry L Bauman2 shared
Most similar at Lovelace Biomedical & Environmental Research Institute
Same institution · by research overlap
- Philip Kuehl$3,625,350
- Yong Lin$2,872,201
- Frederick T Koster$2,691,778
- Amie Kathleen Lund$1,813,316
Others in their field
Top investigators on “Lung Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$351,628,955
- Richard K. Wilson · Washington University$202,666,376
- Walter John Curran · Thomas Jefferson University$94,374,902
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$61,110,512
- William J. Blot · Vanderbilt University$59,429,890
- Charles A Coltman · Southwest Oncology Group$54,703,213
Research focus
Lung NeoplasmsMonitorEpigenetic ProcessLungMalignant Neoplasm Of LungMethylationClinical TrialsDistantGene ExpressionGrowthChemotherapyCell LineBaseCharacteristicsCancer PatientClinicCancer ModelDiagnosisCancer TherapyExcisionGenesGenome-WideCellsNon-Small-Cell Lung Carcinoma
Grant awards (7)
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy$381,186
R01 · FY2020 · CA · contact PI
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy$586,195
R01 · FY2019 · CA · contact PI
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy$581,451
R01 · FY2018 · CA · contact PI
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy$535,737
R01 · FY2017 · CA · contact PI
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy$506,214
R01 · FY2016 · CA · contact PI
Biomarkers for Epigenetic Therapy of Lung Cancer$253,283
R21 · FY2013 · CA · contact PI
Biomarkers for Epigenetic Therapy of Lung Cancer$222,929
R21 · FY2012 · CA · contact PI